Unknown

Dataset Information

Association between PAI-1 Polymorphisms and Ischemic Stroke in a South Korean Case-Control Cohort.


ABSTRACT: Stroke is the second leading cause of death in the world. Approximately 80% of strokes are ischemic in origin. Many risk factors have been linked to stroke, including an increased level of plasminogen activator inhibitor-1 (PAI-1). PAI-1 levels increase and remain elevated in blood during the acute phase of ischemic stroke, which can impair fibrinolytic activity, leading to coronary artery disease and arterial thrombotic disorders. Here, we present a case-control study of 574 stroke patients and 425 controls seen for routine health examination or treatment for nonspecific dizziness, nonorganic headache, or anxiety for positive family history of stroke at the Bundang Medical Center in South Korea. Polymorphisms in PAI-1 were identified by polymerase chain reaction/restriction fragmen

SUBMITTER: Choi GH 

PROVIDER: S-EPMC10178745 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature